These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2198575)

  • 1. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
    Schmatz DM; Romancheck MA; Pittarelli LA; Schwartz RE; Fromtling RA; Nollstadt KH; Vanmiddlesworth FL; Wilson KE; Turner MJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5950-4. PubMed ID: 2198575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
    Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
    J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast glucan of Pneumocystis carinii cyst wall: an excellent target for chemotherapy.
    Matsumoto Y; Yamada M; Amagai T
    J Protozool; 1991; 38(6):6S-7S. PubMed ID: 1818205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
    Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
    J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat.
    Schmatz DM; Powles MA; McFadden D; Nollstadt K; Bouffard FA; Dropinski JF; Liberator P; Andersen J
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1320-3. PubMed ID: 7574523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-687,781, a new member of the papulacandin family of beta-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity.
    VanMiddlesworth F; Omstead MN; Schmatz D; Bartizal K; Fromtling R; Bills G; Nollstadt K; Honeycutt S; Zweerink M; Garrity G
    J Antibiot (Tokyo); 1991 Jan; 44(1):45-51. PubMed ID: 2001985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.
    Nollstadt KH; Powles MA; Fujioka H; Aikawa M; Schmatz DM
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2258-65. PubMed ID: 7840554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
    Sun P; Tong Z
    Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
    Bartlett MS; Current WL; Goheen MP; Boylan CJ; Lee CH; Shaw MM; Queener SF; Smith JW
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1811-6. PubMed ID: 8843286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii.
    Morris SA; Schwartz RE; Sesin DF; Masurekar P; Hallada TC; Schmatz DM; Bartizal K; Hensens OD; Zink DL
    J Antibiot (Tokyo); 1994 Jul; 47(7):755-64. PubMed ID: 8071120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.
    Ito M; Nozu R; Kuramochi T; Eguchi N; Suzuki S; Hioki K; Itoh T; Ikeda F
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2259-62. PubMed ID: 10952565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition.
    Kottom TJ; Limper AH
    J Biol Chem; 2000 Dec; 275(51):40628-34. PubMed ID: 11013231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfa resistance in mouse-derived Pneumocystis carinii.
    Lane B; Hossler P; Bartlett M; Queener S; O'Reilly T; Smith J; Meshnick S
    J Eukaryot Microbiol; 1996; 43(5):39S. PubMed ID: 8822842
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma (1-->3)-beta-D-glucan measurement and polymerase chain reaction on sputum as practical parameters in Pneumocystis carinii pneumonia.
    Okamoto K; Yamamoto T; Nonaka D; Shin H; Okada K; Hayashi J; Kashiwagi S
    Intern Med; 1998 Jul; 37(7):618-21. PubMed ID: 9711891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats.
    Schmatz DM; Powles MA; McFadden DC; Pittarelli L; Balkovec J; Hammond M; Zambias R; Liberator P; Anderson J
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1964-70. PubMed ID: 1416888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.
    Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Sato I; Furuta T; Tsurumi Y; Hori Y; Hino M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 2000 Sep; 53(9):920-7. PubMed ID: 11099225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pneumocystis carinii pneumonia].
    Szabados A; Schierz G; Deinhardt F
    Internist (Berl); 1985 Jun; 26(6):335-40. PubMed ID: 3897099
    [No Abstract]   [Full Text] [Related]  

  • 20. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.